213875 Approaches of Model Specification for Testing Factor Mean Differences in Higher-order CFA Models

Tuesday, November 9, 2010 : 1:10 PM - 1:30 PM

Jichuan Wang, PhD , Epidemiology and Biostatistics, School of Medicine, The George Washington University, Bowie, MD
Carl G. Leukefeld, DSW , Center on Drug and Alcohol Research, University of Kentucky, Lexington, KY
Because the mean structure part of a higher-order CFA model is generally not identified, it is often a challenge in model specification for testing factor mean differences in multi-group higher-order CFA models. Three different parameter constraint approaches (Approaches A, B, and C) are usually proposed to address the identification problems in such modeling. This study is to discuss and demonstrate applications of the three approaches to testing invariance of factor intercepts/means across groups. The Brief Symptom Inventory 18 (BSI-18) will be used for modeling with two samples of rural drug using populations recruited from Ohio (n=248) and Kentucky (n=225). After the invariance of factorial structure of the BSI-18 is confirmed, invariance of the measurement parameters (e.g., factor loadings, item intercepts, and error variances/covariacnes) and structural parameters (e.g., factor variances/covariances and factor means) are examined across the two drug using populations. Statistical package Mplus is used for modeling.

Learning Areas:
Biostatistics, economics
Conduct evaluation related to programs, research, and other areas of practice
Social and behavioral sciences

Learning Objectives:
1) Discuss the fundamentals of multi-group higher-order CFA models 2) Discuss and demonstrate different model specification approaches (Approaches A, B, and C) for testing factor mean differences in multi-group second-order CFA. 3) Demonstrate how to test model difference using rescaled Chi-squares difference when multivariate normality assumption is violated. 4) Show measurement invariance and structural invariance of SBI-18 scale across different populations.

Keywords: Statistics, Substance Abuse

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified on the content I am responsible for because I have been working in public health studies for about 20 years. Currently, I am professor of epidemiology and biostatistics at the George Washington University, School of Medicine.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.